15d-Deoxy-Δ12,14-prostaglandin J2 modulates collagen type I synthesis in human hepatic stellate cells by inducing oxidative stress

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 5, 2005, Pages 361-367

  Kim, Kyung Ah ^a,b   Lim, Young Suk ^a   Kim, Kang Mo ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a  

^a Seoul National University Hospital   (South Korea)

^b Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; COLLAGEN TYPE 1; REACTIVE OXYGEN METABOLITE; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; DRUG DERIVATIVE; PROSTAGLANDIN D2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; STELLATE CELL; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; LIVER; METABOLISM; PHYSIOLOGY;

ANTIOXIDANTS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; OXIDATIVE STRESS; PROSTAGLANDIN D2;

EID: 25444512351     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.06.003     Document Type: Article

References (33)

1. S.L. Friedman, S. Wei, and W.S. Blaner Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium PDGF Am. J. Physiol. 264 1993 G947 G952
2. M. Pinzani Hepatic stellate (ITO) cells expanding roles for a liver-specific pericyte J. Hepatol. 22 1995 700 706
3. A. Geerts, J.M. Lazou, P. De Bleser, and E. Wisse Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver Hepatology 13 1991 1193 1202
4. A.M. Gressner, and M.G. Bachem Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis Semin. Liver Dis. 10 1990 30 46
5. J. Wu, and M.A. Zern Hepatic stellate cells: a target for the treatment of liver fibrosis J. Gastroenterol. 35 2000 665 672
6. F. Marra, E. Efsen, and R.G. Romanelli Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells Gastroenterology 119 2000 466 478
7. T. Miyahara, L. Schrum, and R. Rippe Peroxisome proliferator-activated receptors and hepatic stellate cell activation J. Biol. Chem. 275 2000 35715 35722
8. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
9. A. Galli, D. Crabb, and D. Price Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells Hepatology 31 2000 101 108
10. L. Li, J. Tao, and J. Davaille 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors J. Biol. Chem. 276 2001 38152 38158
11. S.A. Kliewer, and T.M. Willson The nuclear receptor PPAR gamma - bigger than fat Curr. Opin. Genet. Dev. 8 1998 576 581
12. H. Giles, and P. Leff The biology and pharmacology of PGD2 Prostaglandins 35 1988 277 300
13. A. Pietrangelo, R. Gualdi, G. Casalgrandi, G. Montosi, and E. Ventura Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents J. Clin. Invest. 95 1995 1824 1831
14. R.J. Sokol, D. Twedt, and J.M. McKim Jr. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis Gastroenterology 107 1994 1788 1798
15. S. Kamimura, K. Gaal, R.S. Britton, B.R. Bacon, G. Triadafilopoulos, and H. Tsukamoto Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis Hepatology 16 1992 448 453
16. O. Niemela, S. Parkkila, S. Yla-Herttuala, J. Villanueva, B. Ruebner, and C.H. Halsted Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease Hepatology 22 1995 1208 1214
17. A.E. Reid Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
18. K. Houglum, A. Venkataramani, K. Lyche, and M. Chojkier A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C Gastroenterology 113 1997 1069 1073
19. F.A. Anania, L. Womack, M. Jiang, and N.K. Saxena Aldehydes potentiate alpha (2)(I) collagen gene activity by JNK in hepatic stellate cells Free Radic. Biol. Med. 30 2001 846 857
20. M. Parola, M. Pinzani, and A. Casini Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells Biochem. Biophys. Res. Commun. 194 1993 1044 1050
21. W. Schneiderhan, A. Schmid-Kotsas, and J. Zhao Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis Hepatology 34 2001 729 737
22. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
23. D.S. Straus, G. Pascual, and M. Li 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc. Natl. Acad. Sci. USA 97 2000 4844 4849
24. A. Rossi, P. Kapahi, and G. Natoli Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase Nature 403 2000 103 108
25. A. Castrillo, M.J. Diaz-Guerra, S. Hortelano, P. Martin-Sanz, and L. Bosca Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-delta(12,14)-prostaglandin J(2) in activated murine macrophages Mol. Cell Biol. 20 2000 1692 1698
26. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
27. M. Kondo, T. Oya-Ito, T. Kumagai, T. Osawa, and K. Uchida Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress J. Biol. Chem. 276 2001 12076 12083
28. T. Shibata, T. Yamada, and T. Ishii Thioredoxin as a molecular target of cyclopentenone prostaglandins J. Biol. Chem. 278 2003 26046 26054
29. M. Parola, M. Parola, G. Robino, and M.U. Dianzani 4-Hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis Int. J. Mol. Med. 4 1999 425 432
30. P. Greenwel Acetaldehyde-mediated collagen regulation in hepatic stellate cells Alcoholism Clin. Exp. Res. 23 1999 930 933
31. C.S. Liber Prevention and treatment of liver fibrosis based on pathogenesis Alcoholism Clin. Exp. Res. 23 1999 944 949
32. M. Segawa, K. Kayano, E. Sakaguchi, M. Okamoto, I. Sakaida, and K. Okita Antioxidant, N-acetyl-l-cysteine inhibits the expression of the collagen alpha2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-beta Hepatol. Res. 24 2002 305 315
33. K. Houglum, D.A. Brenner, and M. Chojkier d-Alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation J. Clin. Invest. 87 1991 2230 2235